Hepatitis B virus in the Maghreb Region: From epidemiology to prospective research

Liver International

Volumn 33, Issue 6, 2013, Pages 811-819

  Ezzikouri, Sayeh ^a   Pineau, Pascal ^b   Benjelloun, Soumaya ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b INSTITUT PASTEUR   (France)

Author keywords

HBV; North Africa; Public health; Seroprevalence; Variants

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; DELTA AGENT HEPATITIS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LIVER CELL CARCINOMA; MIXED INFECTION; MUTATION; NONHUMAN; NORTH AFRICA; PEER REVIEW; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; SYSTEMATIC REVIEW; VIRUS GENOME; VIRUS STRAIN;

AFRICA, NORTHERN; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DELIVERY OF HEALTH CARE; EPIDEMIOLOGIC RESEARCH DESIGN; GENOTYPE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HEPATITIS B ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; NEEDS ASSESSMENT; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; PUBLIC HEALTH;

EID: 84878916793     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12135     Document Type: Article

References (87)

1. Lee WM. Hepatitis B virus infections. N Engl J Med 1997; 337: 1733.
2. Chiaramonte M, Pupo A, Menegon T, et al. HBV and HCV infection among non-European Union immigrants in North-East Italy. Epidemiol Infect 1998; 121: 179-83.
3. Hemminki K, Mousavi SM, Brandt A, Ji J, Sundquist J. Liver and gallbladder cancer in immigrants to Sweden. Eur J Cancer 2010; 46: 926-31.
4. Chiaramonte M, Pupo A, Menegon T, et al. HBV and HCV infection among non-European Union immigrants in North-East Italy. Epidemiol Infect 1998; 121: 179-83.
5. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
6. Khalfa S, Ardjoun H. Epidemiology of viral hepatitis in Algeria (French). Med Trop (Mars) 1984; 44: 247-52.
7. Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria (French). Bull Soc Pathol Exot 1995; 88: 225-8.
8. Khelifa F, Thibault V. Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria (French). Pathol Biol (Paris) 2009; 57: 107-13.
9. Elzouki AN. Hepatitis B, C and HIV infection in Libya. Libyan J Infect Dis 2007; 1: 132-3.
10. Khmmaj A, Habas E, Azabi M, Rayani A. Frequency of hepatitis B, C, and HIV viruses among blood donors in Libya. Libyan J Med 2010; 5: 5333.
11. Elzouki AN. Hepatitis B infection in Libya: The magnitude of the problem. Libyan J Infect Dis 2008; 2: 20-5.
12. El-Magrahe H, Furarah AR, El-Figih K, El-Urshfany S, Ghenghesh KS. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya. J Infect Dev Ctries 2010; 4: 168-70.
13. ELahmer O, Zorgani A, Abudher A, Ziglam H. Prevalence of human immunodeciency virus, hepatitis B virus, hepatitis C virus among prison inmates, western Libya. The 22nd Annual European Congress of Clinical Microbiology and Infectious Diseases 2012, (Abstract).
14. Ezzikouri S, Chemin I, Chafik A, et al. Genotype determination in Moroccan hepatitis B chronic carriers. Infect Genet Evol 2008; 8: 306-12.
15. Djeriri K, Laurichesse H, Merle JL, et al. Hepatitis B in Moroccan health care workers. Occup Med (Lond) 2008; 58: 419-24.
16. Sbai A, Baha W, Ougabrai H, et al. Hepatitis B prevalence and risk factors in Morocco. Pathol Biol(Paris) 2012; 60: e65-9.
17. Zohoun A, Hadef R, Zahid H, Benkirane M. Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco (French). Med Trop (Mars) 2011; 71: 513-4.
18. Heikel J, Sekkat S, Bouqdir F, et al. The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic. Eur J Epidemiol 1999; 15: 711-5.
19. Benjelloun S, Bennani A, Sekkat S, Benslimane A. Les hépatites virales au Maroc. Aspects épidémiologique et moléculaire. Journées scientifiques de medecine 2002; 60-4 (Abstract).
20. Belbacha I, Cherkaoui I, Akrim M, Dooley KE, El Aouad R. Seroprevalence of hepatitis B and C among barbers and their clients in the Rabat region of Morocco. East Mediterr Health J 2011; 17: 911-9.
21. Aqodad N, Lahbabi M, Elyousfi M, et al. Prevalence of VHC-Ab and HBsAg among blood donors in Guelmim in the south of Morocco. Hep Intl 2011; 5/11936-0533.
22. Sekkat M. Prévalene de l'Ag HBs chez les femmes enceintes résulats préliminaires d'une étude prospective menée au CHU Hassan II fès Maroc a propos de 156 cas fès: Sidi Mohammed Ben Abdellah, 2010, (Thesis).
23. Rouibaa F, Acharki M, Amrani L, et al. Prevalence of Hepatitis B and C markers in high risk hospitalized patients in Morocco. Arab J Gastroenterol 2008; 9: 70-4.
24. Boulaajaj K, Elomari Y, Elmaliki B, et al. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca (French). Nephrol Ther 2005; 1: 274-84.
25. Lo BB, Meymouna M, Boulahi MA, et al. Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania (French). Bull Soc Pathol Exot 1999; 92: 83-4.
26. Lepers JP, Billon C, Pesce JL, Rollin PE, De Saint-Martin J. Sero-epidemiological study in Mauritania (1985-1986): incidence of treponematosis, hepatitis B virus, HIV virus and viral hemorrhagic fevers (French). Bull Soc Pathol Exot Filiales 1988; 81: 24-31.
27. Mansour W, Malick FZ, Sidiya A, et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol 2012; 84: 1186-98.
28. Rui WZ, Lo Baidy B, N'Diaye M. Hepatitis B virus infection in the school milieu of Kiffa and Selibaby, Mauritania (French). Bull Soc Pathol Exot 1998; 91: 247-8.
29. Mansour W, Aye M, Le Gal F, et al. Impact of Hepatitis B and Delta Viruses Coinfection on Liver Disease in Mauritania. EASL Monothematic Conference: Delta Hepatitis Turkey, Istanbul, 2010;. (Abstract).
30. Mansour W, Bollahi MA, Hamed CT, et al. Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott. Mauritania. J Clin Virol 2012; 55: 12-6.
31. Gorgi Y, Ayed K, Jenhani F, Pichoud C, Trepo C. Prevalence of viral hepatitis B markers in the region of Tataouine (southern Tunisia) (French). Arch Inst Pasteur Tunis 1989; 66: 251-61.
32. Triki H, Ben Slimane S, Ben Mami N, et al. High circulation of hepatitis B virus (HBV) precore mutants in Tunisia, North Africa. Epidemiol Infect 2000; 125: 169-74.
33. Triki H, Said N, Ben Salah A, et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997; 91: 11-4.
34. Jemni L, Chatti N. Epidemiology of hepatitis B virus infection. Tunisie Maghreb Medical 1994; 278: 15-18.
35. Hannachi N, Bahri O, Mhalla S, et al. Hepatitis B virus infection in Tunisian pregnant women: risk factors and viral DNA levels in HBe antigen negative women (French). Pathol Biol (Paris) 2009; 57: e43-7.
36. Ben-Alaya-Bouafif N, Bahri O, Chlif S, et al. Heterogeneity of hepatitis B transmission in Tunisia: risk factors for infection and chronic carriage before the introduction of a universal vaccine program. Vaccine 2010; 28: 3301-7.
37. Hannachi N, Boughammoura L, Marzouk M, et al. Viral infection risk in polytransfused adults: seroprevalence of seven viruses in central Tunisia (French). Bull Soc Pathol Exot 2011; 104: 220-5.
38. Langar H, Triki H, Gouider E, et al. Blood-transmitted viral infections among haemophiliacs in Tunisia (French). Transfus Clin Biol 2005; 12: 301-5.
39. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 1995; 38: 24-34.
40. Kitab B, El Feydi AE, Afifi R, et al. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 2011; 63: 66-75.
41. Borchani-Chabchoub I, Gargouri A, Mokdad-Gargouri R. Genotyping of Tunisian hepatitis B virus isolates based on the sequencing of preS2 and S regions. Microbes Infect 2000; 2: 607-12.
42. Malkin JE, Druilhe P, Courouce AM, Monjour L, Gentilini M. Geographical and ethnical distribution of HBs antigen subtypes in Mauritania. Rev Fr Transfus Immunohematol 1983; 26: 591-7.
43. Couroucé-Pauty A, Plançon A, Soulier JP. Distribution of HBsAg subtypes in the World. Vox Sang 1983; 44: 197-211.
44. Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988; 69: 2575-83.
45. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198: 489-503.
46. Kramvis A, Arakawa K, Yu MC, et al. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 2008; 80: 27-46.
47. Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000; 81: 67-74.
48. Olinger CM, Jutavijittum P, Hubschen JM, et al. Possible new hepatitis B virus genotype, Southeast Asia. Emerg Infect Dis 2008; 14: 1777-80.
49. Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 2008; 82: 5657-63.
50. Kurbanov F, Tanaka Y, Kramvis A, Simmonds P, Mizokami M. When should "I" consider a new hepatitis B virus genotype? J Virol 2008; 82: 8241-2.
51. Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009; 83: 10538-47.
52. Alnagih NM, Bashein AM, Rayes A. HBV genotype D is the most prevalent in Libyan patients. Infectious & Endemic Diseases Scientific Conference 2007; 35-36 (Abstract).
53. Sbai A, Bennani A, Benjouad A, Hassar M. HBV genotypes in Morocco. J Clin Virol 2007; 38: 184-5.
54. Baha W, Ennaji MM, Lazar F, et al. HBV genotypes prevalence, precore and basal core mutants in Morocco. Infect Genet Evol 2012; 12: 1157-62.
55. Bahri O, Cheikh I, Hajji N, et al. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 2006; 78: 353-7.
56. Ayed K, Gorgi Y, Ayed-Jendoubi S, et al. Hepatitis B virus genotypes and precore/core-promoter mutations in Tunisian patients with chronic hepatitis B virus infection. J Infect 2007; 54: 291-7.
57. Hannachi N, Fredj NB, Bahri O, et al. Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia. Virol J 2010; 7: 302.
58. Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 2009; 90: 1622-8.
59. Laras A, Koskinas J, Hadziyannis SJ. In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter. Virology 2002; 295: 86-96.
60. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 2008; 89: 901-9.
61. Du H, Li T, Zhang HY, et al. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection. Liver Int 2007; 27: 240-6.
62. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588-91.
63. Elzouki AN, Belkhair S, Tumi A, Abdulmoti S, Arabi M. Comparison between HBe antigen-negative patients and HBe antigen-positive patients with chronic hepatitis B infection in Benghazi, Libya. Libyan J Infect Dis 2007; 1: 26-31.
64. Benjelloun S, Tong S, Li J, et al. Pre-core mutation associated with lack of hepatitis B e antigenaemia in Moroccan asymptomatic carriers of the virus. Res Virol 1993; 144: 159-67.
65. Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 2008; 23: 474-81.
66. Li MS, Lau TC, Chan SK, et al. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity. PLoS ONE 2011; 6: e21856.
67. Kitab B, Afifi R, El Feydi AE, et al. Genetic variability of Hepatitis B virus in Morocco. Hong Kong: Institut Pasteur International Network Annual Scientific Meeting, 2010;. (Abstract).
68. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011; 378: 73-85.
69. Jenhani F, Ayed K, Gorgi Y, et al. Delta infection in chronic HBs Ag carriers in Tunisia: high prevalence in chronic asymptomatic HBs Ag carriers and in HBs Ag positive cirrhosis. Ann Trop Med Parasitol 1990; 84: 349-53.
70. Belabbes EH. The hepatitis delta virus in Algiers (Algeria). Prog Clin Biol Res 1987; 234: 443-4.
71. Djebbi A, Rebai WK, Bahri O, et al. Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients (French). Pathol Biol (Paris) 2009; 57: 518-23.
72. Tedaldi E, Peters L, Neuhaus J, et al. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis 2008; 47: 1468-75.
73. Ribes J, Cleries R, Rubio A, et al. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer 2006; 119: 687-94.
74. Hooshyar D, Napravnik S, Miller WC, Eron JJ. Effect of hepatitis C coinfection on discontinuation and modification of initial HAART in primary HIV care. AIDS 2006; 20: 575-83.
75. Alter H. Viral hepatitis. Hepatology 2006; 43: S230-4.
76. Berkane S. French Luncheon comment prendre en charge les patients atteints d'hépatite C avec les médicaments disponibles en Algérie. 3rd Paris Hepatitis Conference, Paris, 2009, (Abstract).
77. El Annnaz H, Arrouchi H, Haoudi F, et al. Les Co-infections VIH-VHC et VIH-VHB à l'HMIMV de Rabat. Troisièmes journées de la Société Marocaine d'Immunologie, 2011 (Abstract).
78. Maaref F, Kilani B, Ammari L, et al. Prevalence of hepatitis G, B and C virus infections among positive HIV population in a Tunisian Hospital, La Rabta, Tunis (French). Pathol Biol (Paris) 2011; 59: 213-6.
79. Kamal SM, Mahmoud S, Hafez T, EL-Fouly R. Viral hepatitis A to E in South Mediterranean Countries. Medit J Hemat Infect Dis 2010; 2: e2010001.
80. Kutrani H, El-Gatit A, Shekhteryea A, et al. DemoFigureic factors influencing hepatitis B and C infection in Benghazi. Libyan Arab Jamahiriya. East Mediterr Health J 2007; 13: 85-97.
81. Cacoub P, Ohayon V, Sekkat S, et al. Epidemiologic and virologic study of hepatitis C virus infections in Morocco (French). Gastroenterol Clin Biol 2000; 24: 169-73.
82. Ben Halima S, Bahri O, Maamouri N, et al. Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa. Virol J 2010; 7: 229.
83. IARC Monographs. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. Lyon: IARC Press, 1987; 1-42.
84. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
85. Lu SN, Su WW, Yang SS, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006; 119: 1946-52.
86. Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J Gastroenterol Hepatol 2004; 19: 665-9.
87. Yaghi C, Sharara AI, Rassam P, et al. Hepatocellular carcinoma in Lebanon: etiology and prognostic factors associated with short-term survival. World J Gastroenterol 2006; 12: 3575-80.